86 related articles for article (PubMed ID: 8958647)
1. A retrospective study of red cell maternal antibodies by chemiluminescence.
Downing I; Bromilow IM; Templeton JG; Fraser RH
Vox Sang; 1996; 71(4):226-32. PubMed ID: 8958647
[TBL] [Abstract][Full Text] [Related]
2. [Flow cytometry analysis of IGG subclasses of auto- and alloantibodies in autoimmune hemolytic anemia and hemolytic disease of the newborn].
Lynen R; Neuhaus R; Simson G; Riggert J; Köhler M
Beitr Infusionsther Transfusionsmed; 1994; 32():203-7. PubMed ID: 9480088
[TBL] [Abstract][Full Text] [Related]
3. Measurement of the affinity of anti-D in the serum of immunized mothers and in immunoglobulin preparations with unlabeled antibodies.
Debbia M; Brossard Y; Lambin P
Transfusion; 2005 Jun; 45(6):975-83. PubMed ID: 15934997
[TBL] [Abstract][Full Text] [Related]
4. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
Koelewijn JM; Vrijkotte TG; van der Schoot CE; Bonsel GJ; de Haas M
Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
[TBL] [Abstract][Full Text] [Related]
5. Transplacental IgG subclass concentrations in pregnancies at risk of haemolytic disease of the newborn.
Lubenko A; Contreras M; Rodeck CH; Nicolini U; Savage J; Chana H
Vox Sang; 1994; 67(3):291-8. PubMed ID: 7863629
[TBL] [Abstract][Full Text] [Related]
6. IgG subclasses of anti-A and anti-B antibodies bound to the cord red cells in ABO incompatible pregnancies.
Ukita M; Takahashi A; Nunotani T; Kihana T; Watanabe S; Yamada N
Vox Sang; 1989; 56(3):181-6. PubMed ID: 2728395
[TBL] [Abstract][Full Text] [Related]
7. Prediction of the severity of haemolytic disease of the newborn. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results.
Garner SF; Gorick BD; Lai WY; Brown D; Taverner J; Hughes-Jones NC; Contreras M; Lubenko A
Vox Sang; 1995; 68(3):169-76. PubMed ID: 7625074
[TBL] [Abstract][Full Text] [Related]
8. IgG1 and IgG3 anti-D in maternal serum and on the RBCs of infants suffering from HDN: relationship with the severity of the disease.
Lambin P; Debbia M; Puillandre P; Brossard Y
Transfusion; 2002 Dec; 42(12):1537-46. PubMed ID: 12473131
[TBL] [Abstract][Full Text] [Related]
9. Protection against immune haemolytic disease of newborn infants by maternal monocyte-reactive IgG alloantibodies (anti-HLA-DR).
Dooren MC; Kuijpers RW; Joekes EC; Huiskes E; Goldschmeding R; Overbeeke MA; von dem Borne AE; Engelfriet CP; Ouwehand WH
Lancet; 1992 May; 339(8801):1067-70. PubMed ID: 1349101
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serological, quantitative and cell-mediated functional assays of maternal alloantibodies with the severity of haemolytic disease of the newborn.
Hadley AG; Kumpel BM; Leader KA; Poole GD; Fraser ID
Br J Haematol; 1991 Feb; 77(2):221-8. PubMed ID: 2004024
[TBL] [Abstract][Full Text] [Related]
11. The role of the fetal immune system in the pathogenesis of RhD-hemolytic disease of newborns.
Gurevich P; Erina S; Gershon S; Zusman I
Hum Antibodies; 1997; 8(2):76-89. PubMed ID: 9289392
[TBL] [Abstract][Full Text] [Related]
12. An unusual case of ABO-haemolytic disease of the newborn.
Haque KM; Rahman M
Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):61-4. PubMed ID: 11508073
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analyses of the subclasses of red cell IgG antibodies.
Lynen R; Neuhaus R; Schwarz DW; Simson G; Riggert J; Mayr WR; Köhler M
Vox Sang; 1995; 69(2):126-30. PubMed ID: 8585193
[TBL] [Abstract][Full Text] [Related]
14. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of new maternal alloantibodies after intrauterine transfusion for severe Rhesus disease.
Watson WJ; Wax JR; Miller RC; Brost BC
Am J Perinatol; 2006 Apr; 23(3):189-92. PubMed ID: 16586229
[TBL] [Abstract][Full Text] [Related]
16. A quantitative assay for subclassing IgG alloantibodies implicated in hemolytic disease of the newborn.
Thomas NC; Shirey RS; Blakemore K; Kickler TS
Vox Sang; 1995; 69(2):120-5. PubMed ID: 8585192
[TBL] [Abstract][Full Text] [Related]
17. Placental transfer of naturally acquired, maternal cytomegalovirus antibodies in term and preterm neonates.
Mussi-Pinhata MM; Pinto PC; Yamamoto AY; Berencsi K; de Souza CB; Andrea M; Duarte G; Jorge SM
J Med Virol; 2003 Feb; 69(2):232-9. PubMed ID: 12683413
[TBL] [Abstract][Full Text] [Related]
18. Placental transport of maternal immunoglobulin G in pregnancies at risk of Rh (D) hemolytic disease of the newborn.
Palfi M; Hildén JO; Gottvall T; Selbing A
Am J Reprod Immunol; 1998 May; 39(5):323-8. PubMed ID: 9602250
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies.
Arndt PA; Garratty G
Transfusion; 2004 Sep; 44(9):1273-81. PubMed ID: 15318848
[TBL] [Abstract][Full Text] [Related]
20. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
